跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
6-H2
首页
药物
6-H2
6-H2
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Superagonistic anti-CD28 antibodies
US 2006286104 A1
申请人: TEGENERO AG
优先权: 2006
US
8 件公开
ANTI-HUMAN INTERLEUKIN 36 RECEPTOR MONOCLONAL ANTIBODY AND USE THEREOF
EP 4578873 A4
申请人: QYUNS THERAPEUTICS CO LTD
优先权: 2022
CN
EP
US
WO
6 件公开
Anti-human interleukin 23 monoclonal antibody and application thereof
US 12692303 B1
申请人: QYUNS THERAPEUTICS CO LTD
优先权: 2020
CN
EP
US
WO
5 件公开
ANTI-COMPLEMENT FACTOR C1Q ANTIBODIES AND USES THEREOF
EP 3019240 B1
申请人: ANNEXON INC
优先权: 2013
CN
EP
4 件公开
Antipsychotic indolyl derivatives
US 6310066 B1
申请人: AMERICAN HOME PROD
优先权: 2000
US
3 件公开
Application of anti-CD19 antibody in preparation of leukemia treatment medicine
CN 117024588 A
申请人: HUADAO SHANGHAI BIOMEDICAL CO LTD
优先权: 2016
CN
3 件公开
Pyridine Derivatives and Their Use in The Treatment of Psychotic Disorders
US 2010152175 A1
申请人: GLAXOSMITHKLINE LLC
优先权: 2005
CN
US
2 件公开
PROCESS FOR THE PREPARATION OF NITROGEN-CONTAINING COMPOUNDS
US 2010048936 A1
申请人: PETERS ALEXANDER VOLKER A V
优先权: 2006
CN
US
2 件公开
ANTI-NECTIN-4 ANTIBODIES AND METHODS OF USE THEREOF
WO 2025050221 A1
申请人: ACT 225 BIOTHERAPEUTICS CORP
优先权: 2023
CN
WO
2 件公开
ANTI-HUMAN CD117 MONOCLONAL ANTIBODY AND USE THEREOF
WO 2025152667 A1
申请人: QYUNS THERAPEUTICS CO LTD
优先权: 2024
CN
WO
2 件公开
第 1 / 10 页
上一页
下一页
药物
反馈